Literature DB >> 3219268

A comparison of long-chain triglycerides and medium-chain triglycerides on weight loss and tumour size in a cachexia model.

M J Tisdale1, R A Brennan.   

Abstract

A comparison has been made between the ability of long-chain triglycerides (LCT) and medium-chain triglycerides (MCT) to prevent weight loss induced by the cachexia-inducing colon adenocarcinoma (MAC16) and to reduce tumour size. There was no difference in calorie consumption or nitrogen intake between the various groups. When compared with a normal control high carbohydrate, low fat diet, animals fed MCT showed a reduced weight loss and a marked reduction in tumour size. In contrast neither weight loss nor tumour size differed significantly from the controls in animals fed the LCT diet. An elevated plasma level of 3-hydroxybuturate was found only in the animals fed the MCT diets. Administration of LCT caused an increase in the plasma level of FFA, which was not observed in the MCT group. These results suggest that diets containing MCT would provide the best ketogenic regime to reverse the weight loss in cancer cachexia with a concomitant reduction in tumour size.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219268      PMCID: PMC2246820          DOI: 10.1038/bjc.1988.263

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Cancer, ketosis and parenteral nutrition.

Authors:  R A Conyers; A G Need; T Durbridge; N D Harvey; N Potezny; A M Rofe
Journal:  Med J Aust       Date:  1979-05-05       Impact factor: 7.738

2.  Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.

Authors:  P W Sylvester; C Ip; M M Ip
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

3.  The effect of fatty acid structure on utilization by Ehrlich ascites tumor cells.

Authors:  A A Spector; D Steinberg
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

4.  Effect of dietary 18-carbon fatty acids on growth of transplantable mammary adenocarcinomas in mice.

Authors:  S Abraham; L A Hillyard
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

5.  Thermic effect of medium-chain and long-chain triglycerides in man.

Authors:  T B Seaton; S L Welle; M K Warenko; R G Campbell
Journal:  Am J Clin Nutr       Date:  1986-11       Impact factor: 7.045

6.  The inhibition of malignant cell growth by ketone bodies.

Authors:  B A Magee; N Potezny; A M Rofe; R A Conyers
Journal:  Aust J Exp Biol Med Sci       Date:  1979-10

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Ketone-body metabolism in tumour-bearing rats.

Authors:  A M Rofe; R Bais; R A Conyers
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

9.  Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues.

Authors:  M J Tisdale; R A Brennan
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

10.  Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour.

Authors:  S M Mahony; S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

View more
  9 in total

Review 1.  Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.

Authors:  Rainer J Klement
Journal:  Med Oncol       Date:  2017-06-26       Impact factor: 3.064

2.  The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.

Authors:  Angela M Poff; Csilla Ari; Thomas N Seyfried; Dominic P D'Agostino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

3.  Is there a role for carbohydrate restriction in the treatment and prevention of cancer?

Authors:  Rainer J Klement; Ulrike Kämmerer
Journal:  Nutr Metab (Lond)       Date:  2011-10-26       Impact factor: 4.169

4.  Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.

Authors:  A M Poff; N Ward; T N Seyfried; P Arnold; D P D'Agostino
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 5.  The Role of the Insulin/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link.

Authors:  Laura W Bowers; Emily L Rossi; Ciara H O'Flanagan; Linda A deGraffenried; Stephen D Hursting
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-15       Impact factor: 5.555

6.  The ketogenic diet is not feasible as a therapy in a CD-1 nu/nu mouse model of renal cell carcinoma with features of Stauffer's syndrome.

Authors:  Silvia Vidali; Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Renaud Vatrinet; Andreas Koller; Felix Locker; Tricia Rutherford; Maura O'Donnell; Andrea Stöger-Kleiber; Bridget Lambert; Thomas Klaus Felder; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-07-17

7.  Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.

Authors:  Kristin Werner; Daniela Küllenberg de Gaudry; Lenka A Taylor; Tobias Keck; Clemens Unger; Ulrich T Hopt; Ulrich Massing
Journal:  Lipids Health Dis       Date:  2017-06-02       Impact factor: 3.876

8.  Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.

Authors:  Thomas N Seyfried; George Yu; Joseph C Maroon; Dominic P D'Agostino
Journal:  Nutr Metab (Lond)       Date:  2017-02-23       Impact factor: 4.169

9.  A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.

Authors:  Sepideh Aminzadeh-Gohari; René Günther Feichtinger; Silvia Vidali; Felix Locker; Tricia Rutherford; Maura O'Donnel; Andrea Stöger-Kleiber; Johannes Adalbert Mayr; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2017-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.